CARL ZEISS MEDITEC ADR 1 Cash Flow-to-Debt Ratio
CARL ZEISS MEDITEC ADR 1 cash flow-to-debt ratio. CARL ZEISS MEDITEC ADR 1 (AFXA) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of €144.16 Million could theoretically repay 0% of its total liabilities (€1.28 Billion) in one year. Check cash flow reinvestment rate of CARL ZEISS MEDITEC ADR 1 to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CARL ZEISS MEDITEC ADR 1 (2022–2025)
Cash flow-to-debt ratio of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. Historical debt coverage capacity for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Check CARL ZEISS MEDITEC ADR 1 (AFXA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CARL ZEISS MEDITEC ADR 1 Cash Flow-to-Debt Ratio by Year (2022–2025)
CARL ZEISS MEDITEC ADR 1 cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for CARL ZEISS MEDITEC ADR 1. For the full cash flow conversion analysis, see CARL ZEISS MEDITEC ADR 1 operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €209.86 Million | €1.28 Billion | ▼ -11.1% |
| 2024 | 0.19x | €247.32 Million | €1.34 Billion | ▼ -36.6% |
| 2023 | 0.29x | €250.86 Million | €860.02 Million | ▲ +22.9% |
| 2022 | 0.24x | €188.20 Million | €792.73 Million | — |